288 related articles for article (PubMed ID: 16790701)
1. Omalizumab for asthma.
Strunk RC; Bloomberg GR
N Engl J Med; 2006 Jun; 354(25):2689-95. PubMed ID: 16790701
[No Abstract] [Full Text] [Related]
2. [Omalizumab, an anti-IgE monoclonal antibody to treat severe asthma].
Michils A; Sternon J
J Pharm Belg; 2006; 61(3):83-7. PubMed ID: 17058881
[TBL] [Abstract][Full Text] [Related]
3. [Omalizumab. A monoclonal antibody against IgE].
Hennemann A
Med Monatsschr Pharm; 2004 Dec; 27(12):404-7. PubMed ID: 15646688
[No Abstract] [Full Text] [Related]
4. Omalizumab as add-on therapy to inhaled steroids for asthma.
Hadj Tahar A
Issues Emerg Health Technol; 2004 Jun; (58):1-4. PubMed ID: 15455487
[TBL] [Abstract][Full Text] [Related]
5. Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab.
Nowak D
Respir Med; 2006 Nov; 100(11):1907-17. PubMed ID: 16949266
[TBL] [Abstract][Full Text] [Related]
6. Home therapy with subcutaneous anti-immunoglobulin-E antibody omalizumab in 25 patients with immunoglobulin-E-mediated (allergic) asthma.
Liebhaber M; Dyer Z
J Asthma; 2007 Apr; 44(3):195-6. PubMed ID: 17454337
[No Abstract] [Full Text] [Related]
7. Safety and tolerability of omalizumab in children with allergic (IgE-mediated) asthma.
Milgrom H; Fowler-Taylor A; Vidaurre CF; Jayawardene S
Curr Med Res Opin; 2011 Jan; 27(1):163-9. PubMed ID: 21121874
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR.
Vignola AM; Humbert M; Bousquet J; Boulet LP; Hedgecock S; Blogg M; Fox H; Surrey K
Allergy; 2004 Jul; 59(7):709-17. PubMed ID: 15180757
[TBL] [Abstract][Full Text] [Related]
9. Omalizumab in the treatment of severe asthma: efficacy and current problems.
Pelaia G; Renda T; Romeo P; Busceti MT; Maselli R
Ther Adv Respir Dis; 2008 Dec; 2(6):409-21. PubMed ID: 19124386
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with poorly controlled (moderate-to-severe) allergic asthma.
Ayres JG; Higgins B; Chilvers ER; Ayre G; Blogg M; Fox H
Allergy; 2004 Jul; 59(7):701-8. PubMed ID: 15180756
[TBL] [Abstract][Full Text] [Related]
11. Reduction of the total IgE Level by omalizumab in children and adolescents.
Slavin RG; Jimenez P
J Asthma; 2009 Feb; 46(1):102-3. PubMed ID: 19191148
[No Abstract] [Full Text] [Related]
12. Eosinophilic pneumonia in an asthmatic patient treated with omalizumab therapy: forme-fruste of Churg-Strauss syndrome?
Cazzola M; Mura M; Segreti A; Mattei MA; Rogliani P
Allergy; 2009 Sep; 64(9):1389-90. PubMed ID: 19392997
[No Abstract] [Full Text] [Related]
13. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma.
Busse W; Corren J; Lanier BQ; McAlary M; Fowler-Taylor A; Cioppa GD; van As A; Gupta N
J Allergy Clin Immunol; 2001 Aug; 108(2):184-90. PubMed ID: 11496232
[TBL] [Abstract][Full Text] [Related]
14. Unanswered questions on omalizumab (Xolair) patient selection and follow-up.
Lanier B; Marshall GD
Ann Allergy Asthma Immunol; 2004 Feb; 92(2):198-200. PubMed ID: 14989386
[No Abstract] [Full Text] [Related]
15. Reduction of the total immunoglobulin E level by omalizumab in children and adolescents.
Steiss JO; Rudloff S; Lindemann H; Zimmer KP
J Asthma; 2010 Sep; 47(7):832-3. PubMed ID: 20653498
[No Abstract] [Full Text] [Related]
16. The safety and interpretability of skin tests with omalizumab.
Lieberman P; Rahmaoui A; Wong DA
Ann Allergy Asthma Immunol; 2010 Dec; 105(6):493-5. PubMed ID: 21130393
[No Abstract] [Full Text] [Related]
17. World Asthma and COPD Forum. Clinical trial results with omalizumab.
D'Amato G
IDrugs; 2008 Jul; 11(7):489-92. PubMed ID: 18600594
[No Abstract] [Full Text] [Related]
18. Omalizumab for asthma.
Winchester DE; Jacob A; Murphy T
N Engl J Med; 2006 Sep; 355(12):1281-2. PubMed ID: 16990394
[No Abstract] [Full Text] [Related]
19. [Pneumology. Anti-IgE antibodies in the treatment of asthma].
Leuenberger P; Sauty A; Rochat T
Rev Med Suisse; 2007 Jan; 3(93):56-9. PubMed ID: 17354662
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin E-mediated airway inflammation is active in most patients with asthma.
Hayden ML
J Am Acad Nurse Pract; 2007 Sep; 19(9):439-49. PubMed ID: 17760568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
